Grants and Contributions:

Title:
Neuroprotective peptides for stroke
Agreement Number:
973706
Agreement Value:
$25,000.00
Agreement Date:
Jun 22, 2021 - Mar 31, 2023
Description:
The project aims to develop a peptide capable of directly protecting neurons in the brain from cerebral ischemia (stroke). This peptide will be multi-functional, targeting key components of the neurotoxic signaling cascade caused by cerebral ischemia.
Organization:
National Research Council Canada
Expected Results:

In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators. In the long term, find collaborative solutions to public policy challenges and create stronger innovation systems.

Location:
Sophia Antipolis Cedex, FR
Reference Number:
172-2022-2023-Q2-973706
Agreement Type:
Grant
Report Type:
Grants and Contributions
Recipient Business Number:
108161266
Recipient Type:
Academia
Additional Information:

This agreement has been amended 1 time(s). The end date of this agreements has been modified by 182 days

Amendment Date
Jun 13, 2022
Recipient's Legal Name:
National Center for Scientific Research
Program:
Collaborative Science, Technology and Innovation Program – Ideation Fund
Program Purpose:

The Ideation Fund is intended to encourage, test and validate transformative research ideas generated by teams of NRC scientific personnel and external collaborators with complementary capabilities, acting as a demonstration phase for a continually-evolving suite of research and development (R&D) deliverables at the NRC. The fund supports exploratory research through two mechanisms: the New Beginnings Initiative and the Small Teams Initiative.

NAICS Code:
541710
Amendments: